Tag: Alzheimer’s
Cerebrovascular Risk Factors May Up Risk for Parkinson Disease
Most cerebrovascular risk factors linked to higher risk for subsequent diagnosis of Parkinson disease
Plasma Assay Promising for Diagnosis of Early Alzheimer Disease
Aβ42/Aβ40, age, and APOE ε4 status combination corresponds with amyloid PET with AUC of 0.94
Novel PET Staging System May Help Monitor Alzheimer Disease
Positron emission tomography used to track stages of β-amyloid accumulation in vivo
Physical Activity Linked to Slower Aβ-Related Cognitive Decline
Exercise, lower vascular risk independently attenuate negative link for Aβ burden, cognitive decline
Family History of Dementia Tied to Early Memory Deficits
Reduced paired-associates learning performance observed long before typical onset of Alzheimer disease
Exposure to Anticholinergics May Increase Dementia Risk
Risk up for exposure to anticholinergics including antidepressants, antiparkinson drugs, antipsychotics
Nilvadipine Increases Cerebral Blood Flow in the Hippocampus
CBF did not significantly change in posterior cingulate cortex, other regions of interest in Alzheimer disease
Virtual Reality IDs Navigation Issues in Early Alzheimer Disease
Classification accuracy superior to cognitive tests considered highly sensitive to early disease
Higher LDL-C Levels Linked to Early-Onset Alzheimer Disease
Cases with EOAD have higher levels of LDL-C, greater frequency of rare genetic coding variants of APOB
Thiazide Use May Lower Fracture Risk in Patients With Alzheimer Disease
Longer thiazide use tied to decreased risk for low-energy fractures, hip fractures in Alzheimer disease
